Bioconvergence: How semiconductor innovation is shaping the future of healthcare
Abstract:
Technology is playing an ever-greater role in enabling novel solutions for key challenges in the healthcare sector. From early discovery all the way to therapeutic intervention, creative technology solutions combined with improved biological understanding are driving a bioconvergence wave that can radically impact the future of healthcare. Underlying many of these advances are semiconductor chip technologies. For example, recent advances in artificial intelligence leverage enormous advances in compute power. But the basic silicon nanotechnology that underpins computational improvements can also enable the interrogation of biology at the most fundamental of length scales. In this presentation, I will share some of imec’s work in using chip technologies to develop solutions for life science and medical device applications.
Biography:
Paru Deshpande is Vice President of R&D and Head of the Health Sector at imec. He leads research and innovation programs that leverage advanced semiconductor technologies for healthcare applications. Drawing on a technical background in microelectronics, biomedical engineering, and health technology development, he oversees multidisciplinary teams working on sensing, neurotechnology, wearable devices, diagnostics, and AI-enabled health solutions. At imec he is responsible for translating semiconductor innovation into scalable healthcare solutions through strategic partnerships that connect research, industry, and clinical practice.